Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

BACKGROUND AND AIMS: Teduglutide, a GLP-2 analogue, may restore intestinal structural and functional integrity by promoting repair and growth of the mucosa and reducing gastric emptying and secretion, thereby increasing fluid and nutrient absorption in patients with short bowel syndrome (SBS). This...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jeppesen, P B, Gilroy, R, Pertkiewicz, M, Allard, J P, Messing, B, O'Keefe, S J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2011
Assuntos:
Small Bowel
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3112364/
https://ncbi.nlm.nih.gov/pubmed/21317170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2010.218271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados